Indiana Trust & Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Sell
9,867
-351
-3% -$75.5K 0.68% 29
2026
Q1
$2.22M Hold
10,218
0.69% 25
2025
Q4
$2.33M Sell
10,218
-683
-6% -$156K 0.69% 25
2025
Q3
$2.52M Sell
10,901
-619
-5% -$126K 0.77% 21
2025
Q2
$2.14M Buy
11,520
+200
+2% +$37.2K 0.71% 25
2025
Q1
$2.37M Hold
11,320
0.86% 21
2024
Q4
$2.01M Sell
11,320
-51
-0.4% -$9.38K 0.68% 26
2024
Q3
$2.25M Sell
11,371
-45
-0.4% -$8.4K 0.77% 25
2024
Q2
$1.96M Sell
11,416
-207
-2% -$34.3K 0.72% 24
2024
Q1
$2.12M Buy
11,623
+139
+1% +$24K 0.85% 24
2023
Q4
$1.78M Hold
11,484
0.8% 28
2023
Q3
$1.71M Hold
11,484
0.86% 27
2023
Q2
$1.55M Sell
11,484
-84
-0.7% -$12.3K 0.79% 28
2023
Q1
$1.84M Sell
11,568
-494
-4% -$75.5K 1% 24
2022
Q4
$1.95K Buy
12,062
+9
+0.1% +$1.38K 1.1% 20
2022
Q3
$1.62M Buy
12,053
+200
+2% +$28.7K 0.98% 21
2022
Q2
$1.81M Sell
11,853
-200
-2% -$30.6K 1.01% 19
2022
Q1
$1.95M Sell
12,053
-68
-0.6% -$9.88K 0.94% 19
2021
Q4
$1.64M Buy
12,121
+69
+0.6% +$8.15K 0.76% 32
2021
Q3
$1.3M Sell
12,052
-144
-1% -$16.5K 0.65% 31
2021
Q2
$1.31M Sell
12,196
-12
-0.1% -$1.35K 0.72% 33
2021
Q1
$1.32M Buy
12,208
+12
+0.1% +$1.28K 0.71% 31
2020
Q4
$1.31M Hold
12,196
0.72% 33
2020
Q3
$1.07M Hold
12,196
0.64% 34
2020
Q2
$1.2M Buy
12,196
+69
+0.6% +$6.08K 0.74% 31
2020
Q1
$924K Sell
12,127
-100
-0.8% -$8.52K 0.66% 36
2019
Q4
$1.08M Sell
12,227
-1,796
-13% -$149K 0.6% 40
2019
Q3
$1.06M Sell
14,023
-742
-5% -$50.9K 0.59% 41
2019
Q2
$1.07M Sell
14,765
-2,190
-13% -$172K 0.59% 42
2019
Q1
$1.37M Sell
16,955
-798
-4% -$65.3K 0.71% 38
2018
Q4
$1.64M Sell
17,753
-85
-0.5% -$7.47K 0.91% 30
2018
Q3
$1.69M Sell
17,838
-400
-2% -$37.9K 0.77% 35
2018
Q2
$1.69M Sell
18,238
-1,195
-6% -$117K 0.8% 35
2018
Q1
$1.84M Buy
19,433
+1,351
+7% +$148K 0.85% 33
2017
Q4
$1.75M Buy
18,082
+125
+0.7% +$11.8K 0.81% 35
2017
Q3
$1.6M Hold
17,957
0.77% 39
2017
Q2
$1.3M Sell
17,957
-909
-5% -$61.1K 0.64% 44
2017
Q1
$1.23M Sell
18,866
-1,925
-9% -$121K 0.61% 44
2016
Q4
$1.3M Buy
20,791
+90
+0.4% +$5.49K 0.68% 44
2016
Q3
$1.31M Sell
20,701
-1,900
-8% -$123K 0.65% 45
2016
Q2
$1.4M Buy
22,601
+2,481
+12% +$151K 0.7% 41
2016
Q1
$1.15M Buy
20,120
+11,320
+129% +$631K 0.61% 47
2015
Q4
$576K Sell
8,800
-10,940
-55% -$630K 0.3% 75
2015
Q3
$1.07M Sell
19,740
-165
-0.8% -$10.7K 0.61% 42
2015
Q2
$1.34M Buy
19,905
+11,805
+146% +$771K 0.69% 41
2015
Q1
$474K Sell
8,100
-700
-8% -$42.3K 0.24% 79
2014
Q4
$576K Hold
8,800
0.3% 75
2014
Q3
$508K Hold
8,800
0.27% 77
2014
Q2
$497K Sell
8,800
-51
-0.6% -$2.68K 0.29% 75
2014
Q1
$455K Buy
8,851
+1,900
+27% +$96K 0.28% 77
2013
Q4
$367K Sell
6,951
-525
-7% -$25.8K 0.21% 81
2013
Q3
$334K Sell
7,476
-500
-6% -$22.2K 0.2% 83
2013
Q2
$330K Buy
+7,976
New +$349K 0.27% 80

Other funds holding ABBV

Indiana Trust & Investment Management's ABBV Position: Q2 2026 in Review

Indiana Trust & Investment Management reduced its AbbVie (ABBV) stake by 3.4% in Q2 2026, selling an estimated $75.5K and leaving 9,867 shares worth $2.48M. The position accounts for 0.68% of the portfolio, ranked #29.

Indiana Trust & Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.52M in Q3 2025. 2,211 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Indiana Trust & Investment Management held 9,867 shares of AbbVie worth $2.48M as of Q2 2026.
  • Indiana Trust & Investment Management sold 351 AbbVie shares in Q2 2026, an estimated $75.5K.
  • AbbVie made up 0.68% of Indiana Trust & Investment Management's portfolio in Q2 2026, its #29 holding.
  • Indiana Trust & Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Indiana Trust & Investment Management's AbbVie position peaked at $2.52M in Q3 2025.
  • 2,211 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Indiana Trust & Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.